NWF Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
NWF Advisory Services's BMY Position: Q3 2026 in Review
NWF Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 0.9% in Q3 2026, selling an estimated $3.54K and leaving 6,199 shares worth $387K. The position accounts for 0.04% of the portfolio, ranked #263.
NWF Advisory Services first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. The position peaked at $399K in Q1 2025. 682 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- NWF Advisory Services held 6,199 shares of Bristol-Myers Squibb worth $387K as of Q3 2026.
- NWF Advisory Services sold 56 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.54K.
- Bristol-Myers Squibb made up 0.04% of NWF Advisory Services's portfolio in Q3 2026, its #263 holding.
- NWF Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
- NWF Advisory Services's Bristol-Myers Squibb position peaked at $399K in Q1 2025.
- 682 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on NWF Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.